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Host resistance through immune clearance is predicted to favor
pathogens that are able to transmit faster and are hence more
virulent. Increasing pathogen virulence is, in turn, typically
assumed to be mediated by increasing replication rates. However,
experiments designed to test how pathogen virulence and repli-
cation rates evolve in response to increasing host resistance, as
well as the relationship between the two, are rare and lacking for
naturally evolving host–pathogen interactions. We inoculated 55
isolates of Mycoplasma gallisepticum, collected over 20 y from
outbreak, into house finches (Haemorhous mexicanus) from disease-
unexposed populations, which have not evolved protective immunity
toM. gallisepticum. We show using 3 different metrics of virulence
(body mass loss, symptom severity, and putative mortality rate)
that virulence has increased linearly over >150,000 bacterial gen-
erations since outbreak (1994 to 2015). By contrast, while replica-
tion rates increased from outbreak to the initial spread of resistance
(1994 to 2004), no further increases have occurred subsequently
(2007 to 2015). Finally, as a consequence, we found that any poten-
tial mediating effect of replication rate on virulence evolution was
restricted to the period when host resistance was initially increasing
in the population. Taken together, our results show that pathogen
virulence and replication rates can evolve independently, particu-
larly after the initial spread of host resistance. We hypothesize that
the evolution of pathogen virulence can be driven primarily by pro-
cesses such as immune manipulation after resistance spreads in host
populations.
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Understanding the evolution of pathogen virulence in re-sponse to host resistance is central to predicting and man-
aging pathogenesis (1–3). Current theory predicts a positive
association between the evolution of host immunity and the
evolution of pathogen virulence (4–9), with the common as-
sumption that this positive association is underpinned by in-
creasing replication rates in response to host resistance (5, 6, 8,
10–15). However, experimental tests of the impacts of host re-
sistance on the evolution of pathogen virulence and replication
rates, as well as the relationship between the two, remain ex-
ceptional (2, 16, 17).
In laboratory tests, host resistance can be manipulated
through either vaccination with a recombinant antigen or whole-
parasite immunization, with pathogen responses quantified after
passage through resistant versus susceptible hosts. Using such
approaches, the rodent malaria model Plasmodium chabaudi was
shown to evolve increased virulence when repeatedly passaged
through either vaccinated or immunized mice (16, 17). Parasite
densities, however, only increased in vaccinated mice, with the
faster growing parasites being the more virulent. Whether dif-
ferences in the effectiveness of the immune responses elicited
can explain differences between these findings is unknown. Re-
gardless, these studies demonstrate that experimental increases
in host resistance can drive virulence evolution, as predicted by
theory; however, for some reason, this association only emerges
from increased replication rates in vaccinated hosts (16, 17).
Field tests of the impacts of host resistance on pathogen vir-
ulence and replication rates are more challenging because there
are few host–pathogen systems for which we have documented
natural changes in host resistance and associated changes in path-
ogen virulence over time (18–21). Furthermore, nonresistant hosts
are rarely available, but such hosts are essential for controlled
experiments because changes in pathogen traits need to be mea-
sured experimentally in the absence of the confounding effects of
immune activity and clearance (22). One of the few systems in
which pathogens evolving in hosts of changing resistance were
compared in nonresistant hosts was the myxomatosis outbreak in
introduced European rabbits (Oryctolagus cuniculus) in Australia
(21). In this case, experimental inoculation of nonresistant labo-
ratory rabbits with 3 viral isolates collected at outbreak (in the
1950s) and 15 isolates collected >40 y later (i.e., after rabbits had
become resistant) showed that virulence increased following the
spread of genetic resistance (22). However, whether virulence has
increased linearly or nonlinearly over time and whether increased
virulence was driven by increased replication rates were not
clarified.
One way of addressing these issues is to contrast measures of
virulence and replication rates in a large number of distinct
pathogen isolates encompassing the period before, during, and
after the spread of host resistance. Here, we do so in an infection
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experiment using 55 distinct isolates of an emerging bacterial
pathogen (Mycoplasma gallisepticum) of a wild bird, the North
American house finch (Haemorhous mexicanus). M. gallisepticum
emerged naturally in eastern US populations of house finches in
1994, after a single host shift from poultry (23, 24). In its novel finch
host, this bacterial pathogen colonizes the mucosal surfaces of the
conjunctiva and upper respiratory tract and causes a severe con-
junctivitis, which can lead to blindness and death in the wild through
starvation or predation (25, 26). As a result, its emergence in house
finches gave rise to an epidemic that spread quickly and is thought
to have killed millions (24, 27). In turn, the resulting intense se-
lection pressure led house finches to evolve genetic resistance to
M. gallisepticum within only 12 y (18, 28). Evidence for the evolution
of resistance comes from 2 independent studies. First, following
inoculation with a virulent 2007 bacterial isolate, house finches from
disease-exposed populations displayed significantly lower bacterial
loads than those from unexposed populations (18). These results
cannot easily be explained by population differences other than the
history of disease exposure, because finches from exposed and un-
exposed populations displayed equivalent gene expression in re-
sponse to M. gallisepticum in 2000, before resistance spread in the
exposed populations (18). Transcriptional responses to infection
then diverged as exposed populations evolved the ability to resist
pathogen-induced immunosuppression and mount a protective cell-
mediated immune response (i.e., by 2007) (18, 28). Second, in a
more recent inoculation experiment, we again found evidence for
increased resistance in disease-exposed host populations (29). In this
case, we demonstrated that host and pathogen have coevolved an-
tagonistically since outbreak, a pattern that can only arise when
hosts have evolved resistance in response to infection (30–32).
Here, we inoculated 55 distinctM. gallisepticum isolates collected
from epidemic outbreak, throughout the initial spread of host re-
sistance, and afterward to the present day (1994 to 2015) into
nonresistant houses finches from disease-unexposed populations.
While using resistant hosts would be necessary for determining the
consequence of pathogen evolution on achieved pathogen load and
virulence in coevolved hosts, using nonresistant hosts here is critical
because tests of genetically determined changes in pathogen traits
need to be conducted in a host environment in which measures are
not confounded by protective immunity (16, 17, 22). Further, the
isolates used were collected at random from naturally infected
finches displaying natural variation in symptom severity. Given that
symptoms are required for transmission, our isolates therefore
comprise a representative sample of the transmitting isolates cir-
culating during the epidemic (29). Finally, maximizing the number
of pathogen isolates used, rather than using a few isolates with
multiple replicates, allowed us to adopt a regression-based experi-
mental approach specifically designed to elucidate the shape of the
relationships between pathogen traits and time against background
variation in hosts (33, 34). Thus, our approach allows a novel test of
1) how pathogen virulence has changed over the course of a nat-
urally evolving epidemic; 2) how replication rates have done so; and
3) whether replication rate is positively and linearly associated with
virulence, supporting the hypothesis that replication rate drives
virulence evolution (5, 6, 8, 10–15).
Results
Effect of Year of Pathogen Sampling on Virulence. We quantified
virulence as the severity of damage done to the host, measured as
the amount of body mass lost and the level of conjunctival
swelling reached during the infection, as well as putative mor-
tality rates inferred from severity of symptoms (Methods). All 3
measures of virulence were highly variable. For example, mass
loss averaged 0.86 g (SD = 0.96 g, equivalent to a 5% reduction
for an average body mass of 18.8 g) during the course of the
experiment, whereas conjunctival swelling varied by 87% among
individuals and 36% of birds recorded symptoms of a severity
tantamount to death in the wild (25, 26, 35). The key questions
are whether this variation can be explained by year of pathogen
sampling and, if so, what the shape of the relationship is between
year of pathogen sampling and metrics of virulence.
First, we found a significant negative association between the
amount of mass lost and year of pathogen sampling, with those
birds exposed to isolates sampled progressively later in the epidemic
losing more mass (linear mixed model; linear year effect: estimate ±
SE = −0.06 ± 0.02, t53 = −3.3, P < 0.002; Fig. 1A). This pattern was
found even after controlling for significant effects of initial body
mass (estimate ± SE = −0.3 ± 0.1, t53 = −2.9, P < 0.006); further, we
found no evidence to suggest that the relationship between mass
loss and year of pathogen sampling was nonlinear (quadratic year
effect: estimate ± SE = 0.7 ± 0.9, t50 = 0.8, P = 0.42). Second, we
similarly found that quantitative variation in the average conjunc-
tival swelling of individuals also increased as a linear function of
the year of pathogen sampling (linear mixed model; linear year
effect: estimate ± SE = 1.4 ± 0.4, t43 = 3.6, P < 0.001; quadratic year
effect: estimate ± SE = −10.1 ± 17.7, t42 = −0.6, P = 0.57; Fig. 1B).
Finally, we found a significant effect of year of pathogen sampling
on host putative survival probability (log rank test: χ2 = 97.1, n = 57,
Fig. 1. Evolution of virulence. We show body mass changes (in grams; cal-
culated as body mass at the end of the experiment − body mass at in-
oculation) (A) and mean conjunctival swelling (in pixels) in symptomatic
hosts (B) as a function of the year of pathogen sampling. Points represent
raw values; the line is predicted from the model, with the SE represented by
the ribbon. Note that some points are overlapping. (C) Survival probability
(0/1, defined by severity of symptoms; Methods) over the course of the ex-
periment (in days) for the different years of pathogen sampling (displayed
on the right); isolates sampled before versus after the spread of resistance
are colored in gray and black, respectively.
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P < 0.0001; Fig. 1C), with the probability of putative survival de-
creasing from 100% in birds inoculated with outbreak isolates (i.e.,
1994 to 1996) to 25% for those inoculated with 2007 isolates (after
the initial spread of host resistance), and then to 10% in those in-
oculated with 2015 isolates. To elucidate whether survival prob-
ability decreased linearly with year of pathogen sampling, we
analyzed how survival probabilities changed before versus after
resistance initially spread in the host population. In support of a
linear association, we found that the change in survival probability
from pathogen emergence through the initial spread of host re-
sistance was of comparable magnitude to the change measured
over the same period of time after resistance had initially spread
(logistic regression; year of pathogen sampling × sampling period
interaction effect: estimate ± SE = 18.2 ± 1,883.0, z = 0.01, P =
0.99). Together, these results provide rare experimental support
for the hypothesis that pathogen virulence is driven, at least in
part, by increasing host resistance, and moreover suggest that
virulence can continue to increase linearly over the evolutionary
time period encompassed in this study (i.e., 20 y is equivalent to
>150,00 bacterial generations).
Effect of Year of Pathogen Sampling on Pathogen Load and
Replication Rates. First, we investigated the function of the re-
lationship between pathogen load and year of pathogen sampling.
Pathogen load was measured as both the peak load and total load,
with the latter calculated as the integral of pathogen load over the
course of the 34-d experiment. The peak pathogen load averaged
83 ± 96 (SD) bacterial cells per host cell, while the total load over
the experiment averaged 1,190 ± 1,440 (SD) bacterial cells per host
cell. Both measures of pathogen load showed a significant positive,
but quadratic, relationship with year of pathogen sampling (peak:
estimate ± SE = 5.2 ± 1.1, z = 4.9, P < 0.0001 [linear effect]; esti-
mate ± SE = −2.3 ± 1.1, z = −2.2, P = 0.03 [quadratic effect]; total:
estimate ± SE = 4.9 ± 1.1, z = 4.4, P < 0.0001 [linear effect];
estimate ± SE = −2.8 ± 1.1, z = −2.0, P = 0.046 [quadratic effect]; SI
Appendix, Fig. S1 A and B). Second, we investigated the relationship
between replication rate and year of pathogen sampling. In nonre-
sistant hosts from disease-unexposed populations, replication rate
can be estimated as pathogen load divided by the time required to
reach that load. However, because the timing to peak pathogen load
varied among isolates (averaging 15.5 ± 8 d postinoculation [dpi]),
replication rate was measured by dividing peak pathogen load by the
number of days to peak load. Again, we found a significant quadratic
relationship between replication rate and year of pathogen sam-
pling (linear model; linear effect of sampling year: estimate ±
SE = 5.0 ± 1.1, z = 4.6, P < 0.0001; quadratic effect of sampling
year: estimate ± SE = −2.9 ± 1.1, z = −2.7, P = 0.008; Fig. 2).
Association between Replication Rates and Virulence. A common
assumption is that increasing replication rates underpin the pre-
dicted positive association between the evolution of host resistance
and the evolution of pathogen virulence (5, 6, 8, 10–15). That both
pathogen load and replication rate increase during the early, but not
later, phase of the epidemic (Fig. 2 and SI Appendix, Fig. S1 A and
B), while our 3 measures of virulence increased linearly throughout
(Fig. 1 A–C), suggests that any relationship between replication rate
and virulence will be restricted to the early phase of the epidemic at
best. First, we found little evidence for a linear association between
replication rates and virulence throughout the epidemic. Notably,
variation in replication rates had little impact on mass loss, and
there was no evidence that replication rate was associated with
mean conjunctival swelling or the probability of putative survival
(Table 1). Second, however, we found that this lack of association
for conjunctival swelling (although not for the other 2 measures of
virulence) was confounded by year of pathogen sampling. In other
words, there was a positive association between replication rate and
conjunctival swelling before the spread of resistance, but no sig-
nificant association thereafter (analysis of covariance; replication
rate × sampling period interaction effect: estimate ± SE = 1.3 ± 0.7,
t41 = −2.0, P = 0.048; Fig. 3). These results suggest that the re-
lationship between replication rate and virulence can be weak and
that replication rate is not the primary driver of the increase in
virulence following the spread of host resistance.
Discussion
Our results show that the virulence of M. gallisepticum has in-
creased linearly from outbreak (1994), through the spread of house
finch resistance (to 2007), to the present day (2015). Specifically,
nonresistant house finches (i.e., from disease-unexposed pop-
ulations) lost significantly more body mass, displayed more severe
conjunctival swelling, and had lower putative survival probability
when inoculated with isolates sampled at increasingly later time
points in the epidemic. In contrast to linear increases in virulence,
pathogen loads and replication rate displayed significant quadratic
relationships with year of isolate sampling, with pathogen load and
replication rate increasing from disease outbreak to the spread of
host resistance, but not thereafter. Finally, we found limited evidence
for an association between replication rate and our 3 measures of
virulence, despite the common assumption that virulence evolution
is underpinned by changing replication rates (5, 6, 8, 10–15). To-
gether, our results support the hypothesis that increasing host re-
sistance drives the evolution of increasing pathogen virulence, but
not the assumption that this increase in virulence is mediated pri-
marily by increasing replication rates (5, 6, 8, 10–15).
The “trade-off” hypothesis proposes that increases in pathogen
fitness, represented by the number of secondary infections arising
from a single infected host, can be achieved either by accelerating
between-host transmission or by lengthening the duration of in-
fection within the host, but not both (2, 5, 6, 36). One central
prediction of this hypothesis is that by reducing infection duration
through pathogen clearance and by alleviating the cost of virulence
through reduced host mortality, host resistance should select for
increased pathogen virulence (7–9). Although this prediction has
been upheld in laboratory studies (16, 17), where pathogens are
passaged through hosts of manipulated resistance, experimental
tests of virulence responses to natural changes in host resistance
are rare (20, 22). In one such test, the virulence of the myxoma
virus was broadly found to increase in association with the in-
creasing resistance of the rabbit host (37). [Although there was an
initial decrease in virulence, this was likely an effect of the high
virulence of the strains that were used during this eradication at-
tempt (38).] In another test, house finch conjunctival swelling
scores were found to be greater when inoculated with a 2008 iso-
late of M. gallisepticum (when resistance had spread) compared
with a 1994 isolate at outbreak (20). However, our study based on
55 isolates collected before, during, and after the initial spread of
host resistance provides evidence to suggest that virulence (mea-
sured in 3 different ways) has not only increased since outbreak,
but has done so at a comparable rate throughout the epidemic.
Fig. 2. Evolution of replication rate. Replication rates (ratio of pathogen
cells to host cells per day), measured as the rate at which peak pathogen
load was reached at the site of infection, as a function of the year of
pathogen sampling, from epidemic outbreak (1994) to over 20 y later (2015).
Points represent raw values; the line is predicted from the model, with the SE
represented by the ribbon. Rerunning this analysis without the 3 obvious
outliers generated qualitatively comparable results and made the quadratic
effect stronger (SI Appendix, Fig. S2C).
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Pathogen virulence is assumed to be mediated primarily
through variation in pathogen replication rates (11, 13, 14, 39),
so much so that pathogen load has been used as a surrogate for
virulence (40). Despite this, current evidence for a tight link
between replication rates and virulence is mixed (10, 14, 16, 17,
41–43). For variation in the replication rates of M. gallisepticum
to mediate variation in virulence, both variables (replication rate
and virulence) need to show equivalent patterns of response over
time as hosts evolve resistance. On the contrary, however, while
virulence shows a linear increase over the course of the epi-
demic, this is not the case for our measures of replication rate,
which all showed an increase between disease outbreak and the
initial spread of host resistance, but not thereafter. In other
words, our measures of replication rate showed a quadratic, not
linear, relationship with year of pathogen sampling. Further ex-
periments are required to fully understand the basis of these
quadratic relationships between year of pathogen sampling and
replication rate or pathogen load, but there are 2 likely hy-
potheses for what we observed. First, replication rates may have
already been optimized for pathogen transmission by the time
host resistance spread in the population, with insufficient sub-
sequent selection to drive the evolution of further increases.
Alternatively, following the initial spread of host resistance, se-
lection might have primarily operated on other fitness-maximizing
traits in the pathogen, which are antagonistic to further increases
in replication rates. Either way, our results suggest that replication
rate is not the primary driver of the evolution of increasing viru-
lence in M. gallisepticum, especially following the initial spread of
resistance in house finches.
The weak associations between metrics of virulence and replica-
tion rates suggest that another pathogen trait, in addition to repli-
cation rate, accounts for significant variation in virulence. One likely
candidate is the ability to manipulate the host immune system (44,
45). Evidence suggests that immune manipulation is critical to the
success of M. gallisepticum infection (46–49). First, M. gallisepticum
invades the mucosal surfaces of the conjunctiva and upper res-
piratory tract by inducing a misdirected inflammatory response, with
more virulent strains inducing greater responses (46, 47, 50–55). For
example, chickens experimentally inoculated with a virulent strain of
M. gallisepticum (Rlow) display greater up-regulation of proin-
flammatory cytokines, which are responsible for local and systemic
inflammation, and associated tissue destruction and local necrosis,
than chickens inoculated with a more attenuated strain (GT5) (56).
Second, the subsequent persistence ofM. gallisepticum then depends
on the bacterium’s ability to evade and suppress other immune
components known to play a role in controlling M. gallisepticum
infection (54). For example, chickens infected with M. gallisepticum
display lower T cell activity 2 wk postinoculation than controls (52,
53), as well as lower humoral responses against other pathogens (57,
58). Similarly, we have shown previously that house finches from
unexposed populations are unable to up-regulate the expression of
genes associated with acquired immunity (cell-mediated immunity),
again consistent with persistence being facilitated by the suppression
of protective immune processes (18, 28). Finally, between-host
transmission occurs through eye droplets transferred directly or
left on inert surfaces as fomites, which are produced as ocular
secretions resulting from inflammation (59). Thus, while the sup-
pression of pathogen-specific immune processes is required for
M. gallisepticum persistence, the up-regulation of nonspecific,
damaging inflammatory processes is required for successful path-
ogen colonization and transmission. In this system, it therefore
seems reasonable to hypothesize that there is independent selection
on virulence and replication rate, leading to linear increases in the
former, but not in the latter, over the course of the epidemic.
Our results have at least 4 important implications for host–
pathogen interactions:
1) Increasing host resistance has given rise to linear increases in
pathogen virulence, at least over the estimated >150,000 bac-
terial generations encompassed in this study.
2) By contrast, replication rates appear to have been under di-
rectional selection between pathogen outbreak and the initial
spread of resistance, but not thereafter.
3) As a consequence, virulence evolution and replication rates can
be under independent selection pressures, and the potentially
Table 1. Summary of relationships between metrics of virulence and replication rates over the
course of the epidemic
Model Estimate ± SE Statistics P R2
1. Response: body mass change
Replication rate <−0.01 ± <0.01 t52 = −0.7 0.48 0.02
Replication rate2 0.3 ± 1.0 t51 = 0.4 0.72 0.02
Replication rate × sampling period −0.03 ± 0.03 t50 = −1.0 0.31 0.08
2. Response: mean conjunctival swelling
Replication rate 0.13 ± 0.31 t43 = 0.4 0.66 0.02
Replication rate2 −27.6 ± 19.8 t42 = −1.4 0.17 0.06
Replication rate × sampling period 1.4 ± 0.7 t41 = 2.0 <0.05 0.25
3. Response: survival probability
Replication rate 0.07 ± 0.04 z = 1.6 0.10
Replication rate2 −1.1 ± 2.4 z = −0.5 0.64
Replication rate × sampling period 0.03 ± 0.09 z = 0.3 0.74
The sampling period was categorized as before (1994 to 2004) versus after (2007 to 2015) the spread of host
resistance. The single significant effect is provided in boldface.
Fig. 3. Association between replication rates (ratio of pathogen cells to
host cells per day) and virulence, as measured by mean conjunctival swelling
(in pixels). We show the association for pathogen isolates sampled before (in
gray) versus after (in black) the spread of host resistance. Points represent raw
values; lines are predicted from the model (dashed lines, isolates sampled
preresistance; solid lines, isolates sampled postresistance), with SEs represented
by ribbons. None of the other analyses investigating the relationship between
replication rate and other measures of virulence was significant (Table 1).
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weak associations between the 2 suggest that replication rates
should not be used as a metric of virulence.
4) Finally, we hypothesize that selection on immune manipula-
tion is dominant over that on replication rate following the
initial spread of host resistance, but this hypothesis remains
to be tested in this and other systems.
Methods
Capture and Housing. Wild house finches from populations that have never
been exposed to M. gallisepticum (i.e., that have not evolved genetic re-
sistance) were captured in variety of urban and suburban sites in Arizona in
the summer of 2015 (n = 57, 30 males and 27 females). M. gallisepticum has
never been recorded in the sampling area despite continuous monitoring
(60). Using birds that have not had the opportunity to evolve protective
immune responses to M. gallisepticum is essential for measuring genetically
determined virulence and replication rate in the pathogen without the
confounds of the capacity for immune clearance (22). There is currently no
evidence in this or any other system to suggest that genetically determined
levels of virulence and replication rate are modified by differences in host
resistance, but our ability to measure each will obviously be curtailed if done
so in resistant hosts. Birds that had hatched in the spring of 2015 were
trapped, weighed, and banded with a numbered metal tag for individual
identification. They were then immediately transported by car to indoor
aviaries at Arizona State University’s Tempe campus, where they were
housed for the remainder of the experiment. On arrival, we obtained a
blood sample from all birds using brachial venipuncture (60 μL of whole
blood) and a choanal swab. A lack of prior infection with M. gallisepticum
since hatching was confirmed by screening blood plasma for anti-M. galli-
septicum antibodies using a serum plate agglutination assay (61), and a lack
of current infection was verified using the choanal swabs in PCR amplifica-
tion of M. gallisepticum DNA (62).
Experimental Inoculation. Each of the 55 M. gallisepticum isolates sampled
over the course of the epidemic was inoculated into 1 bird selected at ran-
dom from the 57, although 2 isolates (1 each from 1995 and 2007) were
inoculated in 2 birds. Maximizing the number of pathogen isolates used is
essential for clarifying the shape of the relationship between pathogen traits
and time in a regression-based statistical approach (33, 34). The alternative of
using fewer isolates replicated across multiple hosts would be more appropriate
to fully characterize differences among pathogen isolates, but that was not the
aim of the study. Further, evidence of evolution requires systematic changes in
trait values over time that are observable against random background variation
in ecology. In the context of our study, this random ecological variation is rep-
resented by inevitable slight among-host variation in the response to infection
(although recall that none of the birds used has evolved resistance). By randomly
pairing each bird with a distinct pathogen isolate (but occasional exceptions are
discussed above), any slight variation in host responses to infection will be
randomly distributed over the years of pathogen sampling. Thus, while the
precise value of a given point will likely include some impact of host response,
the shape of the regression slopes of pathogen traits over time will reflect the
patterns of pathogen evolution. Finally, isolates were obtained over a 20-y pe-
riod at random from naturally infected, wild-caught house finches from various
urban and suburban sites in 8 different states in the eastern United States
(mainly from Alabama). Given thatM. gallisepticum requires inducing symptoms
for successful transmission, our isolates are therefore a representative sample of
those successfully circulating within the host population at a given time.
Isolates were obtained by swabbing the conjunctiva of a symptomatic bird
and placing the swab in SP4 growth medium. Isolates were administered via
20 μL of culture containing 1 × 104 to 1 × 106 color-changing units per
milliliter of M. gallisepticum in both eyes. Later quantification of the num-
ber of bacterial cells in each inoculum was determined using qPCR (discussed
below), and concentrations of the inoculums were found to range from 4.1 ×
105 to 3.0 × 106 bacterial cells per microliter (average ± SE = 1.4 × 106 ± 0.6 ×
106 bacterial cells per microliter). To account for any variation in the number
of bacterial cells inoculated (i.e., dose), we verified that there was no cor-
relation between dose and year of sampling of the isolate (Spearman’s rank
correlation: P = 0.49), and we included dose as a covariate in all our analyses
(Statistical Analyses). None of the isolates had been passaged in culture
more than 3 times (63). All 57 birds were maintained individually in separate
cages with ad libitum food and water from the time they were inoculated
and throughout the duration of the 34-d experiment. The experiment was
stopped at 35 dpi, and all birds were euthanized as stipulated by home
office licensing. Protocols were approved by Institutional Animal Care and
Use Committees of Arizona State University (permit 15-1438R), as well as by
Institutional Biological Use Authorizations to Auburn University (BUA 500),
and by the University of Exeter’s Ethics Committee.
Symptom Severity. We have shown previously that mass loss is indicative of
the severity of infection in nonresistant birds from unexposed populations, and
so can be used as a measure of virulence (64). All birds were weighed (±0.01 g)
at the start and end of the experiment using a top-pan balance. To quantify
the size of the conjunctiva, and so the severity of conjunctival swelling, we
photographed the right and left eyes at 0, 6, 13, and 25 dpi from a stan-
dardized distance. We then measured the average area of the conjunctiva
swelling across the 2 eyes and at each day as follows: the area of the outer ring
minus the area of the inner ring at 6, 13, or 25 dpi − the area of the outer ring
minus the area of the inner ring at 0 dpi (65). Measurements of photographs
were done blindly with respect to the isolate inoculated. Finally, eyes were also
inspected visually on days 3, 6, 8, 14, 21, 25, 28, and 34 postinfection: Infection
is considered lethal when the conjunctiva is red to purple and the eye is dif-
ficult to see and produces discharge. Such symptoms, with little or no vision
possible, are thought to have caused the death of millions of infected finches
due to starvation or predation (25, 35, 62).
Bacterial Load. Bacterial load was measured from conjunctival and tracheal
swabs obtained at 8, 14, 21, and 28 dpi by quantifying the number of M.
gallisepticum mgc2 gene copies and the number of house finch rag1 gene
copies using a redesigned qPCR assay (assay design, validation, and details
are shown in SI Appendix, Tables S1 and S2). Pathogen load was then de-
termined as the number of M. gallisepticum cells divided by the number of
house finch cells to control for variation in sampling efficiency (66). DNA was
extracted using a QIAGEN DNeasy Blood and Tissue Kit according to the
manufacturer’s standard protocols.
Statistical Analyses. All statistical analyses were conducted in R version 3.3.2
(67), and figures were made using ggplot2 (68). We verified that any variation
in the number of bacterial cells inoculated (i.e., dose) did not confound our
results. There was no correlation between the dose inoculated and the year of
pathogen sampling (as discussed above), and dose was not a significant
covariate in any of our analyses (all P > 0.5). These results show that any slight
variation in dose inoculated was not systematically biased toward isolates of
high virulence, and that it was not sufficient to confound any of our results.
Virulence. Analyses of mass loss and conjunctival swelling were conducted
using linear models with normal error structures, with dose inoculated
and year of pathogen sampling fitted as fixed terms. For changes in body
mass, we also included initial bodymass at inoculation as a covariate. Putative
survival probability over time was analyzed using a log-rank test with year of
pathogen sampling and dose inoculated as explanatory terms. Further, dif-
ferences in temporal changes in survival probability from outbreak to the
spread of host resistance versus an equivalent period of time after resistance
had spread were modeled using a logistic regression with survival (0/1) as the
response variable, andwith year of pathogen sampling, sampling period (pre-
vs. postresistance), their interaction, and dose inoculated as explanatory terms.
Pathogen load and replication rate. Most isolates achieved a low pathogen load
and showed relatively low rates of replication, although some displayed
substantial levels of each. As a consequence, these data followed a negative
binomial distribution, and so were analyzed using generalized linear models
with negative binomial error structures and logarithm link functions (69, 70),
and with dose inoculated, year of pathogen sampling, and year of pathogen
sampling2 fitted as fixed terms. It is important to note that such log-link
functions do not log-transform the response term, but exponentiate the
explanatory term. As such, quadratic relationships between year of patho-
gen sampling and measures of pathogen load and replication rate are not
expected by chance in these models.
Association between replication rate and virulence. To test for associations be-
tween replication rates and virulence, we ran linear models with either body
mass change or conjunctival swelling as the response variable and logistic
regressions with survival (0/1) as the response variable. Potential explanatory
terms included were replication rate, replication rate2, and the interaction
between replication rate and sampling period (pre- vs. postresistance). Dose
inoculated was fitted as a covariate, but this was never significant.
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